Asaf Danziger
2021
In 2021, Asaf Danziger earned a total compensation of $1.2M as Chief Executive Officer at NovoCure, a 87% decrease compared to previous year.
Compensation breakdown
| Salary | $876,086 |
|---|---|
| Other | $303,197 |
| Total | $1,179,283 |
Danziger received $876.1K in salary, accounting for 74% of the total pay in 2021.
Danziger also received $303.2K in other compensation.
Rankings
In 2021, Asaf Danziger's compensation ranked 8,186th out of 12,415 executives tracked by ExecPay. In other words, Danziger earned more than 34.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,186 out of 12,415 | 34th |
Division Manufacturing | 3,621 out of 5,508 | 34th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 464 out of 801 | 42nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 291 out of 522 | 44th |
Industry Surgical and Medical Instruments and Apparatus | 187 out of 327 | 43rd |
Source: SEC filing on April 25, 2022.
Danziger's colleagues
We found four more compensation records of executives who worked with Asaf Danziger at NovoCure in 2021.